Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Smart Needle Knows Where It’s Going

February 27, 2019 By Tierney King

Getting shots and seeing needles are two events many try to avoid when going to the doctor’s office. Nonetheless, it’s been a way to deliver medication for more than a century. However, pinpointing the exact spot to insert a needle is no easy feat, especially in regions like the suprachoroidal space at the back of the eye. Now, researchers from Brigham and Women’s Hospital have developed a ‘smart’ needle that detects changes in resistance in order to properly and safely deliver medication. The highly sensitive intelligent-injector for tissue-targeting (i2T2) is currently being used in preclinical testing, and the results have been published in Nature Biomedical Engineering.

“Targeting specific tissues using a conventional needle can be difficult and often requires a highly trained individual,” says senior corresponding author Jeff Karp, Ph.D., Professor of Medicine at the Brigham. “In the past century there has been minimal innovation to the needle itself, and we saw this as an opportunity to develop better, more accurate devices. We sought to achieve improved tissue targeting while keeping the design as simple as possible for ease of use.”

As mentioned previously, the suprachoroidal space (SCS), located between the sclera and choroid in the back of the eye, is an extremely difficult location to target with a standard needle. Despite its difficulty, the SCS has emerged as an important location for medication delivery. The challenge arises because the needle must stop transitioning through the sclera, which is less than 1 millimeter thick, in order to prevent damage to the retina. Other common tissue targets include the epidural space around the spinal cord, the peritoneal space in the abdomen, and subcutaneous tissue between the skin and muscles.

The i2T2 device was created using a standard hypodermic needle and parts from other commercially available syringes. While body tissues have different densities, the injector uses the differences in pressure to project needle movement into a specific, target tissue. The driving force, maximal forces, and frictional force of the injector were tested using the universal testing machine. The feedback of the injector is instant, and allows for more precise tissue targeting and minimal overshoot into an undesired location.

“This intelligent injector is a simple solution that could be rapidly advanced to patients to help increase target tissue precision and decrease overshoot injuries. We have completely transformed needles with a small modification that achieves better tissue targeting,” says first author Girish Chitnis, Ph.D., a former postdoctoral fellow in Karp’s laboratory. “This is a platform technology, so the uses could be very widespread.”

In total, the device was tested on tissue from three animal models to determine its accuracy in the suprachoroidal, epidural, and peritoneal spaces. Researchers found that the i2T2 prevented overshoot tissues and delivered medication to the location without additional training.

During preclinical models, researchers reported high coverage of contrast agent in the posterior section of the eye, which indicated that the payload had been injected into the correct location. Researchers also showed that the device could deliver stem cells to the back of the eye for potential regenerative therapies.

“The stem cells injected into the SCS survived, indicating that the force of injection and the transit through the SCS were gentle on the cells,” says Kisuk Yang, a co-author and postdoctoral fellow in Karp’s laboratory. “This should open the door to regenerative therapies for patients suffering from conditions of the eye and beyond.”

The researchers plan to continue their exploration of this smart needle’s capabilities and hope to, someday soon, use it on humans.

“The i2T2 will help facilitate injections in difficult-to-target locations in the body,” says Miguel González-Andrades, MD, Ph.D., ophthalmologist co-author of the manuscript and collaborator with Karp’s lab. “The next step toward human use is to demonstrate the utility and safety of the technology in relevant pre-clinical disease models.”

Related Articles Read More >

Nanoscopic imaging showing human keratinocyte-matrix interaction.
These smart materials are key to advancing regenerative medicine
A series of before-and-after brain scans showing improvement in long COVID patients after hyperbaric oxygen therapy
Long COVID study finds potential in hyperbaric oxygen therapy
Rockwell Experience Center opens at Dean Kamen’s Advanced Regenerative Manufacturing Institute
What is microscale 3D printing? Lessons learned from Mayo Clinic
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe